News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alitair Pharmaceuticals Announces Issuance Of An Additional Patent Covering Its Platform Drug Delivery Technology, REA™


1/22/2014 9:26:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MORRISTOWN, N.J.--(BUSINESS WIRE)--Alitair Pharmaceuticals, Inc., a revenue-stage pharmaceutical company with multiple respiratory product candidates in development, today announced the issuance of U.S. Patent No. 8,617,602 from the United States Patent and Trademark Office (USPTO) for its ion exchange resin drug delivery technology, REA™.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES